🇺🇸 FDA
Pipeline program

Sativex

GWEXT0101

Phase 3 small_molecule completed

Quick answer

Sativex for Pain is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals plc with 6 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Pain
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials